Disease | primary sclerosing cholangitis |
Phenotype | C0206698|cholangiocarcinoma |
Sentences | 15 |
PubMedID- 23894567 | Various cohort studies showed an increased occurrence of cholangiocarcinoma in patients with primary sclerosing cholangitis, ranging from 10% to 13% [6]–[8]. |
PubMedID- 25636976 | Colorectal cancer and cholangiocarcinoma in patients with primary sclerosing cholangitis and inflammatory bowel disease. |
PubMedID- 25500329 | Background: the diagnosis of cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc) is particularly difficult. |
PubMedID- 24577150 | Trends in pre-liver transplant screening for cholangiocarcinoma among patients with primary sclerosing cholangitis. |
PubMedID- 20216413 | An update on cholangiocarcinoma associated with primary sclerosing cholangitis. |
PubMedID- 25623660 | Objectives: polysomy detected by fluorescence in situ hybridization (fish) is associated with cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc). |
PubMedID- 25259419 | Early diagnosis of dysplastic changes and exclusion of cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc) remain a major clinical challenge. |
PubMedID- 21374660 | Early detection of malignant biliary tract diseases, especially cholangiocarcinoma (cc) in patients with primary sclerosing cholangitis (psc), is very difficult and often comes too late to give the patient a therapeutic benefit. |
PubMedID- 21603286 | Ca19-9 was useful for predicting cholangiocarcinoma in patients with primary sclerosing cholangitis, with the sensitivity being 79%, the specificity 99%, the adjusted positive predictive value 57% and the negative predictive value 99% (49). |
PubMedID- 23007734 | Background: carbohydrate antigen 19-9 (ca 19-9) is the serum marker used to diagnose cholangiocarcinoma (cca) in patients with primary sclerosing cholangitis (psc). |
PubMedID- 20508074 | A case of intrahepatic cholangiocarcinoma associated with primary sclerosing cholangitis. |
PubMedID- 23958938 | Fut2 and fut3 genotype determines ca19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis. |
PubMedID- 26176037 | Background/aims: primary sclerosing cholangitis (psc) is often complicated by cholangiocarcinoma (cca); thus, early detection of cca is an important way to improve psc prognosis. |
PubMedID- 21884553 | De novo cholangiocarcinoma associated with recurrent primary sclerosing cholangitis in the transplanted liver is rare. |
PubMedID- 25690752 | Liver transplantation and whipple surgery combined with chemoradiotherapy for treatment of hilar cholangiocarcinoma in patients with primary sclerosing cholangitis. |
Page: 1